![Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade | British Journal of Cancer Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01819-1/MediaObjects/41416_2022_1819_Fig1_HTML.png)
Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade | British Journal of Cancer
![SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes | Nature Communications SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-22905-7/MediaObjects/41467_2021_22905_Fig1_HTML.png)
SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes | Nature Communications
![Multiple parameters shape the 3D chromatin structure of single nuclei at the doc locus in Drosophila | Nature Communications Multiple parameters shape the 3D chromatin structure of single nuclei at the doc locus in Drosophila | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-32973-y/MediaObjects/41467_2022_32973_Fig1_HTML.png)
Multiple parameters shape the 3D chromatin structure of single nuclei at the doc locus in Drosophila | Nature Communications
![Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study - The Lancet Rheumatology Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study - The Lancet Rheumatology](https://www.thelancet.com/cms/asset/3ebd0253-5fcf-4189-af5a-96dca7f46a78/gr1.jpg)
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study - The Lancet Rheumatology
![A blind benchmark of analysis tools to infer kinetic rate constants from single-molecule FRET trajectories | Nature Communications A blind benchmark of analysis tools to infer kinetic rate constants from single-molecule FRET trajectories | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33023-3/MediaObjects/41467_2022_33023_Fig1_HTML.png)
A blind benchmark of analysis tools to infer kinetic rate constants from single-molecule FRET trajectories | Nature Communications
![Cell cycle gene regulation dynamics revealed by RNA velocity and deep-learning | Nature Communications Cell cycle gene regulation dynamics revealed by RNA velocity and deep-learning | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-30545-8/MediaObjects/41467_2022_30545_Fig1_HTML.png)
Cell cycle gene regulation dynamics revealed by RNA velocity and deep-learning | Nature Communications
![Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial - The Lancet Infectious Diseases Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/79907246-571c-4f11-a6f3-6edc308e58c1/gr1.jpg)